Dynamic Ultrasound of the Calf Muscles After Stroke (Stroke_DynUS)

June 3, 2024 updated by: University Hospital, Ghent

Het Gebruik Van Dynamische Echografie om Spier-pees Veranderingen te Onderzoeken in de Kuitspieren Van Personen na Een CVA: Een Pilootstudie

Muscle behaviour of calf muscles can be studied during dynamic conditions using dynamic ultrasound. In particular, the medial gastrocnemius is suitable for measurements with dynamic ultrasound due to its superficial location. With this measurement technique, the muscle behavior during walking can be observed gaining insight into the mechanism of action of this muscle during a functional task. This technique has already been used in other populations (such as children with cerebral palsy) but not yet in individuals after a stroke.

Therefore, the aim of this study is to assess the muscle behavior of the medial gastrocnemius during walking in persons after stroke. There are 3 concrete objectives of the current study:

  1. is the technique feasible to perform in persons after stroke?
  2. does the use of the dynamic echoprobe change gait patterns?
  3. can differences between persons after stroke and healthy controls be detected? This data can be used as pilot data for project applications in the future that will allow to design larger studies.

Therefore, 10 stroke patients and 10 age- and gender-matched healthy controls will walk on a treadmill for 3x2 minutes after a familiarisation period of 6 minutes.

During 1 x 2 minutes, subjects will walk without using the dynamic ultrasound. This recording aims to measure the normal gait pattern of the subjects.

During the other 2x2 minutes, subjects will walk using the dynamic ultrasound at 2 different locations on the calf. Once with the ultrasound probe on the centre of the muscle belly to visualise muscle fibre bundles and once on the muscle tendon transition, from which muscle belly and tendon length can be derived.

The use of ultrasound or not will be randomized to exclude the effect of fatigue on the outcome measures.

Study Overview

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium, 9000
        • Ghent University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Stroke group Inclusion criteria

  • stroke adults
  • no other neurologic conditions
  • ability to walk independently on a treadmill

Exclusion criteria

  • wearing ankle foot orthosis that inhibit the assessment
  • had lower limb surgery in the past

Healthy volunteers Inclusion criteria

- healthy adults

Exclusion criteria

  • suffering from any neurological condition
  • had lower limb surgery in the past

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Healthy controls
Dynamic changes of the calf muscles during walking will be assessed in persons after stroke and compared to healthy controls
Experimental: Stroke patient
Dynamic changes of the calf muscles during walking will be assessed in persons after stroke and compared to healthy controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fascicle dynamics measured with ultrasound during walking
Time Frame: single point assessment in one day during walking with the probe
Lengthening and shortening of the fascicles of the medial gastrocnemius
single point assessment in one day during walking with the probe
Muscle belly dynamics measured with ultrasound during walking
Time Frame: single point assessment in one day during walking with the probe
Lengthening and shortening of the muscle belly of the medial gastrocnemius
single point assessment in one day during walking with the probe
Tendon dynamics measured with ultrasound during walking
Time Frame: single point assessment in one day during walking with the probe
Lengthening and shortening of the tendon of the medial gastrocnemius
single point assessment in one day during walking with the probe

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gait speed
Time Frame: single point assessment in one day during walking with the probe
walking velocity (m/s)
single point assessment in one day during walking with the probe
gait speed
Time Frame: single point assessment in one day during walking without the probe
walking velocity (m/s)
single point assessment in one day during walking without the probe
step width
Time Frame: single point assessment in one day during walking with the probe
step width (m)
single point assessment in one day during walking with the probe
step width
Time Frame: single point assessment in one day during walking without the probe
step width (m)
single point assessment in one day during walking without the probe
Step length
Time Frame: single point assessment in one day during walking with the probe
Step length (m) of the paretic and non paretic side
single point assessment in one day during walking with the probe
Step length
Time Frame: single point assessment in one day during walking without the probe
Step length (m) of the paretic and non paretic side
single point assessment in one day during walking without the probe
stance phase
Time Frame: single point assessment in one day during walking with the probe
time spend standing on the paretic and non-paretic leg (s) during walking
single point assessment in one day during walking with the probe
stance phase
Time Frame: single point assessment in one day during walking without the probe
time spend standing on the paretic and non-paretic leg (s) during walking
single point assessment in one day during walking without the probe
swing phase
Time Frame: single point assessment in one day during walking with the probe
time spend not standing on the paretic and non-paretic leg (s) during walking
single point assessment in one day during walking with the probe
swing phase
Time Frame: single point assessment in one day during walking without the probe
time spend not standing on the paretic and non-paretic leg (s) during walking
single point assessment in one day during walking without the probe
lower limb kinematics
Time Frame: single point assessment in one day during walking with the probe
joint angles (°) in the pelvis, hip, knee and ankle in the sagittal, frontal and transverse plane during walking
single point assessment in one day during walking with the probe
lower limb kinematics
Time Frame: single point assessment in one day during walking without the probe
joint angles (°) in the pelvis, hip, knee and ankle in the sagittal, frontal and transverse plane during walking
single point assessment in one day during walking without the probe

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2024

Primary Completion (Actual)

April 4, 2024

Study Completion (Actual)

April 4, 2024

Study Registration Dates

First Submitted

January 17, 2024

First Submitted That Met QC Criteria

January 31, 2024

First Posted (Actual)

February 9, 2024

Study Record Updates

Last Update Posted (Estimated)

June 4, 2024

Last Update Submitted That Met QC Criteria

June 3, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ONZ-2023-0497
  • B6702023000632 (Registry Identifier: Belgium register)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Dynamic ultrasound of the calf muscles

Subscribe